Mehra, Rohit http://orcid.org/0000-0002-6955-8884
Salami, Simpa S.
Lonigro, Robert
Bhalla, Ritu
Siddiqui, Javed
Cao, Xuhong
Spratt, Daniel E.
Palapattu, Ganesh S.
Palanisamy, Nallasivam
Wei, John T.
Chinnaiyan, Arul M.
Tomlins, Scott A.
Funding for this research was provided by:
National Institute of Health (CA214170)
Article History
Received: 10 August 2018
Accepted: 27 September 2018
First Online: 5 October 2018
Compliance with ethical standards
:
: The University of Michigan has been issued a patent on the detection of ETS gene fusions in prostate cancer, in which R.M., S.A.T., and A.M.C. are listed as co-inventors. The University of Michigan has licensed the diagnostic field of use to Gen-Probe, Inc. (Bedford, MA), which has sublicensed some rights to Ventana Medical Systems. S.A.T. serves as a consultant to and has received honoraria from Ventana Medical Systems. A.M.C. has served as a consultant for Gen-Probe, Inc. and Ventana Medical Systems. All other authors have no disclosures.